This content is restricted.
Brief
The Commission Implementing Regulation (EU) 2024/2563 amends Implementing Regulation (EU) 2022/1646 to provide additional content for national risk-based control plans and national randomised surveillance plans. This regulation requires Member States to submit updated data and plans, including minimum sampling frequencies, and specifies the competent authorities responsible for implementing these plans, thereby ensuring compliance with Union legislation on pharmacologically active substances.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested